Sept. 19, 2023, 4:19 p.m. | Antonio Regalado

MIT Technology Review

Google DeepMind says it’s trained an artificial intelligence that can predict which DNA variations in our genomes are likely to cause disease—predictions that could speed diagnosis of rare disorders and possibly yield clues for drug development. DeepMind, founded in London and acquired by Google 10 years ago, is known for artificial-intelligence programs that play video…

acquired artificial artificial intelligence biotechnology and health deepmind development diagnosis disease dna drug development google google deepmind intelligence london predictions speed

More from / MIT Technology Review

Senior AI/ML Developer

@ | Remote

Consultant(e) Confirmé(e) Power BI & Azure - H/F

@ Talan | Lyon, France

Research Manager-Data Science

@ INFICON | East Syracuse, NY, United States

Data Scientist

@ Ubisoft | Singapore, Singapore

Data Science Assistant – Stage Janvier 2024 (F/H/NB)

@ Ubisoft | Paris, France

Data Scientist

@ dentsu international | Milano, Italy